Red man syndrome (RMS) is a potential adverse reaction related to vancomycin administration. Symptoms include flushing, erythema, and pruritus of the upper body as well as chest or back pains and hypotension. Differential diagnosis includes anaphylaxis, which features wheezing, dyspnea, and angioedema. RMS is caused by vancomycin activating mast cells. Risk factors include certain antibiotics, opioids, plasma expanders, and mastocytosis. RMS can be prevented by administering vancomycin at concentrations less than 5 mg/ml at rates less than 10 mg/min, and premedicating with diphenhydramine and famotidine. Treatment involves
2. Symptoms of RMS
? Flushing, erythema, and pruritus, usually of
the upper body.
? Chest or back pains and hypotension may also
occur.
3. Differential diagnosis
? Symptoms of anaphylaxis overlap with those
of severe RMS, although wheezing, significant
dyspnea, and angioedema are more
suggestive of anaphylaxis.
6. Prevention of RMS
? (Administration)
? conc.+5mg/ml and rate+10mg/min ´.eg. 1 g
in 200ml NS or D5W, drip over >100 min
? (Premedication)
? Diphenhydramine (50 mg orally) \ famotidine
(20 mg orally) 1 hour before infusion
7. Treatment
? Stop infusion
? Diphenhydramine (50 mg IV) \ famotidine (20
mg IV)
? Intravenous fluids may be needed for
hypotension
? Afterwards, re-infusing any subsequent doses
of vancomycin over four hours